• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Revelation Biosciences Inc (NQ: REVB )

    1.790 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.790
    Bid (Size) 1.710 (1)
    Ask (Size) 1.990 (2)
    Prev. Close 1.790
    Today's Range 1.790 - 1.790
    52wk Range 0.2770 - 25.26
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Why Is Nano-Cap Revelation Biosciences Stock Skyrocketing On Monday?
    Revelation Biosciences reveals positive safety and biomarker data from its Phase 1 study (RVL-HV02) of Gemini. The study met its primary endpoint and identified a maximum tolerated dose. 
    Via Benzinga
    Revelation Biosciences Announces Phase 1 Clinical Study of Gemini Met the Primary Safety Endpoint and Showed Statistically Significant Biomarker Activity
    From Revelation Biosciences, Inc.
    Via Business Wire

    Performance

    YTD
    +250.98%
    +250.98%
    1 Month
    -6.77%
    -6.77%
    3 Month
    -30.89%
    -30.89%
    6 Month
    +250.98%
    +250.98%
    1 Year
    +90.43%
    +90.43%

    More News

    Read More
    Revelation Biosciences Has Completed Dosing of its First in Human Phase 1 Clinical Study of Gemini
    From Revelation Biosciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Friday's After-Market Session
    Via Benzinga
    REVB Stock Earnings: Revelation Biosciences Misses EPS for Q1 2024
    Via InvestorPlace
    Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
    From Revelation Biosciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's Pre-Market Session
    Via Benzinga
    REVB Stock Earnings: Revelation Biosciences Beats EPS for Q4 2023
    Via InvestorPlace
    Revelation Biosciences, Inc. Announces Financial Results for the Three and Twelve Months Ended December 31, 2023
    From Revelation Biosciences, Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Via Benzinga
    Revelation Biosciences Inc. Gives Oral Presentation at Advances in Critical Care Nephrology (AKI & CRRT 2024)
    From Revelation Biosciences Inc.
    Via Business Wire
    Revelation Biosciences Inc. to Participate in a Virtual Fireside Chat at the 36th Annual Roth Conference
    From Revelation Biosciences Inc.
    Via Business Wire
    Revelation Biosciences Inc. Announces Commencement of First in Human Phase 1 Clinical Study of Gemini
    From Revelation Biosciences Inc.
    Via Business Wire
    Revelation Biosciences Inc. Receives Invitation to Give an Oral Presentation at The 29th International Conference on Advances in Critical Care Nephrology (AKI & CRRT 2024)
    From Revelation Biosciences Inc.
    Via Business Wire
    Top 5 Health Care Stocks That Are Preparing To Pump In February
    Via Benzinga
    BioMedNewsBreaks – Revelation Biosciences Inc. (NASDAQ: REVB) Secures ~$6.2M in Public Offering
    Via Investor Brand Network
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Revelation Biosciences Inc. Announces Closing of $6.2 Million Public Offering
    From Revelation Biosciences Inc.
    Via Business Wire
    12 Health Care Stocks Moving In Monday's After-Market Session
    Via Benzinga
    Why Skechers Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
    Via Benzinga
    Why Meta Shares Are Trading Higher By Over 16%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    Dow Jumps 250 Points; Honeywell Issues Weak Forecast
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Crude Oil Gains 1%; ISM Manufacturing PMI Tops Expectations
    Via Benzinga
    Topics Stocks
    Exposures Fossil Fuels US Equities
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.